{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T09:31:55Z","timestamp":1781343115114,"version":"3.54.1"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T00:00:00Z","timestamp":1532044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["18QA1402500"],"award-info":[{"award-number":["18QA1402500"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014175","name":"Shanghai Municipal Health and Family Planning Commission","doi-asserted-by":"publisher","award":["2017EKHWYX-02"],"award-info":[{"award-number":["2017EKHWYX-02"]}],"id":[{"id":"10.13039\/501100014175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014175","name":"Shanghai Municipal Health and Family Planning Commission","doi-asserted-by":"publisher","award":["2017ZZ02026"],"award-info":[{"award-number":["2017ZZ02026"]}],"id":[{"id":"10.13039\/501100014175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014175","name":"Shanghai Municipal Health and Family Planning Commission","doi-asserted-by":"publisher","award":["GDEK201709"],"award-info":[{"award-number":["GDEK201709"]}],"id":[{"id":"10.13039\/501100014175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014137","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","award":["16CR2025B"],"award-info":[{"award-number":["16CR2025B"]}],"id":[{"id":"10.13039\/501100014137","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"publisher","award":["2014CB910300"],"award-info":[{"award-number":["2014CB910300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571031"],"award-info":[{"award-number":["81571031"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81761128035"],"award-info":[{"award-number":["81761128035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81730095"],"award-info":[{"award-number":["81730095"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91632304"],"award-info":[{"award-number":["91632304"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701334"],"award-info":[{"award-number":["81701334"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81781220701"],"award-info":[{"award-number":["81781220701"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771214"],"award-info":[{"award-number":["81771214"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","award":["20152234"],"award-info":[{"award-number":["20152234"]}],"id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ebiom.2018.07.031","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T11:49:31Z","timestamp":1532605771000},"page":"201-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Quercetin Reduces Cortical GABAergic Transmission and Alleviates MK-801-Induced Hyperactivity"],"prefix":"10.1016","volume":"34","author":[{"given":"Hui-Ran","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Feng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Jiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyue","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shining","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tailin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Le","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Guang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2455-4986","authenticated-orcid":false,"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2018.07.031_bb0005","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0022-3565(24)35047-5","article-title":"Characterization of MK-801-induced behavior as a putative rat model of psychosis","volume":"290","author":"Andine","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pharmthera.2009.09.001","article-title":"Preclinical and clinical pharmacology of the GABAA receptor alpha5 subtype-selective inverse agonist alpha5IA","volume":"125","author":"Atack","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00213-008-1357-7","article-title":"RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors","volume":"202","author":"Ballard","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0020","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.schres.2015.02.024","article-title":"Glycinamide prevents MK-801-induced hyperactivity and deficits in object recognition memory in an animal model of positive and cognitive symptoms of schizophrenia","volume":"166","author":"Basurto","year":"2015","journal-title":"Schizophr Res"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nn.2447","article-title":"Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes","volume":"13","author":"Belforte","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0030","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.neuron.2015.03.042","article-title":"The GABAA receptor as a therapeutic target for neurodevelopmental disorders","volume":"86","author":"Braat","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuron.2011.12.012","article-title":"Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease","volume":"73","author":"Brickley","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0040","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09511","article-title":"Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke","volume":"468","author":"Clarkson","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0045","doi-asserted-by":"crossref","first-page":"2986796","DOI":"10.1155\/2016\/2986796","article-title":"Mechanisms of neuroprotection by quercetin: counteracting oxidative stress and more","volume":"2016","author":"Costa","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10673229609017192","article-title":"The glutamatergic dysfunction hypothesis for schizophrenia","volume":"3","author":"Coyle","year":"1996","journal-title":"Harv Rev Psychiatry"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0055","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10571-006-9062-8","article-title":"Glutamate and schizophrenia: beyond the dopamine hypothesis","volume":"26","author":"Coyle","year":"2006","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0060","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/schbul\/sbs076","article-title":"NMDA receptor and schizophrenia: a brief history","volume":"38","author":"Coyle","year":"2012","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0065","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuint.2015.07.002","article-title":"Quercetin in brain diseases: potential and limits","volume":"89","author":"Dajas","year":"2015","journal-title":"Neurochem Int"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0070","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/sj.npp.1300772","article-title":"Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic","volume":"30","author":"Depoortere","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002826-198902000-00001","article-title":"A \u201cglutamatergic hypothesis\u201d of schizophrenia. Rationale for pharmacotherapy with glycine","volume":"12","author":"Deutsch","year":"1989","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-3-319-28383-8_12","article-title":"Role of quercetin benefits in neurodegeneration","volume":"12","author":"Elumalai","year":"2016","journal-title":"Adv Neurobiol"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.conb.2013.12.001","article-title":"Interneuronal GABAA receptors inside and outside of synapses","volume":"26","author":"Ferando","year":"2014","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0090","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nn1860","article-title":"Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome","volume":"10","author":"Fernandez","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0095","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s12272-001-1217-2","article-title":"Quercetin: further investigation of its antinociceptive properties and mechanisms of action","volume":"31","author":"Filho","year":"2008","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/nn0110-2","article-title":"Testing the glutamate hypothesis of schizophrenia","volume":"13","author":"Gordon","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0105","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.bjp.0705657","article-title":"Studies on the mechanisms of action of picrotoxin, quercetin and pregnanolone at the GABA rho 1 receptor","volume":"141","author":"Goutman","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-2999(03)01309-8","article-title":"Flavonoid modulation of ionic currents mediated by GABA(A) and GABA(C) receptors","volume":"461","author":"Goutman","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/7854_2016_466","article-title":"Effect of hallucinogens on unconditioned nehavior","volume":"36","author":"Halberstadt","year":"2018","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pnpbp.2003.09.026","article-title":"Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice","volume":"28","author":"Hansen","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0125","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature05324","article-title":"Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites","volume":"444","author":"Hosie","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature09552","article-title":"Rethinking schizophrenia","volume":"468","author":"Insel","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainres.2010.03.033","article-title":"Effects of quercetin on the sleep-wake cycle in rats: involvement of gamma-aminobutyric acid receptor type A in regulation of rapid eye movement sleep","volume":"1330","author":"Kambe","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0140","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12272-014-0409-2","article-title":"Differential effects of quercetin glycosides on GABAC receptor channel activity","volume":"38","author":"Kim","year":"2015","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0145","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature06493","article-title":"Reversal of pathological pain through specific spinal GABAA receptor subtypes","volume":"451","author":"Knabl","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0150","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1016\/j.bmcl.2009.08.053","article-title":"The discovery and unique pharmacological profile of RO4938581 and RO4882224 as potent and selective GABAA alpha5 inverse agonists for the treatment of cognitive dysfunction","volume":"19","author":"Knust","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0893-133X(94)00131-I","article-title":"Subanesthetic doses of ketamine stimulate psychosis in schizophrenia","volume":"13","author":"Lahti","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0165","doi-asserted-by":"crossref","first-page":"13770","DOI":"10.1038\/ncomms13770","article-title":"ASIC1a regulates insular long-term depression and is required for the extinction of conditioned taste aversion","volume":"7","author":"Li","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0170","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/jcmm.13313","article-title":"Neuroprotection by quercetin via mitochondrial function adaptation in traumatic brain injury: PGC-1alpha pathway as a potential mechanism","volume":"22","author":"Li","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0175","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1113\/jphysiol.2003.047324","article-title":"Mechanisms of H+ modulation of glycinergic response in rat sacral dorsal commissural neurons","volume":"552","author":"Li","year":"2003","journal-title":"J Physiol"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0180","doi-asserted-by":"crossref","first-page":"46654","DOI":"10.1038\/srep46654","article-title":"Curcumol allosterically modulates GABA(A) receptors in a manner distinct from benzodiazepines","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0185","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0014-2999(82)90022-X","article-title":"Effects of phencyclidine on excitatory amino acid activation of spinal interneurones in the cat","volume":"77","author":"Lodge","year":"1982","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0190","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1146\/annurev.ne.17.030194.003033","article-title":"GABAA receptor channels","volume":"17","author":"MacDonald","year":"1994","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0195","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/0929867013373723","article-title":"Biological properties of citrus flavonoids pertaining to cancer and inflammation","volume":"8","author":"Manthey","year":"2001","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0200","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1523\/JNEUROSCI.1203-12.2013","article-title":"Reducing GABAA alpha5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome","volume":"33","author":"Martinez-Cue","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0205","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0166-2236(96)80023-3","article-title":"Which GABAA-receptor subtypes really occur in the brain?","volume":"19","author":"McKernan","year":"1996","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0210","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-med-050911-161504","article-title":"Update on typical and atypical antipsychotic drugs","volume":"64","author":"Meltzer","year":"2013","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0215","first-page":"900","article-title":"New trends in the treatment of schizophrenia","volume":"16","author":"Meltzer","year":"2017","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0220","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1017\/S1461145713000928","article-title":"Translating the N-methyl-d-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia","volume":"16","author":"Meltzer","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0225","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/38738","article-title":"Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors","volume":"389","author":"Mihic","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0230","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment","volume":"37","author":"Moghaddam","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0235","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.mad.2004.01.007","article-title":"Molecular imaging of the biological effects of quercetin and quercetin-rich foods","volume":"125","author":"Moskaug","year":"2004","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0240","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0006-8993(90)91323-9","article-title":"Serotonin suppresses N-methyl-d-aspartate responses in acutely isolated spinal dorsal horn neurons of the rat","volume":"525","author":"Murase","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0245","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1177\/0748233713518603","article-title":"Comparison between the effects of quercetin on seizure threshold in acute and chronic seizure models","volume":"32","author":"Nassiri-Asl","year":"2016","journal-title":"Toxicol Ind Health"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0250","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.0954-6820.1950.tb12129.x","article-title":"On treatment of barbiturate poisoning","volume":"137","author":"Nilsson","year":"1950","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0255","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neuropharm.2015.04.012","article-title":"Subchronic phencyclidine treatment in adult mice increases GABAergic transmission and LTP threshold in the hippocampus","volume":"100","author":"Nomura","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0260","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature09647","article-title":"X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel","volume":"469","author":"Nury","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0265","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.neuropharm.2007.08.008","article-title":"Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist","volume":"53","author":"Nutt","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0270","first-page":"275","article-title":"Safety of quercetin for clinical application (review)","volume":"16","author":"Okamoto","year":"2005","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0275","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update","volume":"60","author":"Olsen","year":"2008","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0280","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2008.07.045","article-title":"GABA A receptors: subtypes provide diversity of function and pharmacology","volume":"56","author":"Olsen","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0285","series-title":"The mouse brain in stereotaxic coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0290","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1124\/jpet.110.166710","article-title":"Behavioral indices in antipsychotic drug discovery","volume":"333","author":"Porsolt","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0295","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fnmol.2016.00044","article-title":"Structural studies of GABAA receptor binding sites: which experimental structure tells us what?","volume":"9","author":"Puthenkalam","year":"2016","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0300","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbr.2018.05.005","article-title":"Neurosteroid pregnenolone sulfate, alone, and as augmentation of lurasidone or tandospirone, rescues phencyclidine-induced deficits in cognitive function and social interaction","volume":"350","author":"Rajagopal","year":"2018","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0305","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00213-011-2593-9","article-title":"Negative modulation of GABAA alpha5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats","volume":"221","author":"Redrobe","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0310","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuron.2006.09.015","article-title":"Neurobiology of schizophrenia","volume":"52","author":"Ross","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0315","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0320","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-pharmtox-011613-135947","article-title":"GABAA receptor subtypes: therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism","volume":"54","author":"Rudolph","year":"2014","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0325","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/ncomms2682","article-title":"Structural basis for potentiation by alcohols and anaesthetics in a ligand-gated ion channel","volume":"4","author":"Sauguet","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0330","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nn1043","article-title":"GABA uptake regulates cortical excitability via cell type-specific tonic inhibition","volume":"6","author":"Semyanov","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0335","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.biopha.2016.10.011","article-title":"Bioactive effects of quercetin in the central nervous system: focusing on the mechanisms of actions","volume":"84","author":"Suganthy","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0340","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/cercor\/bhl087","article-title":"Molecular basis for the GABAA receptor-mediated tonic inhibition in rat somatosensory cortex","volume":"17","author":"Yamada","year":"2007","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0345","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nchembio.1340","article-title":"A propofol binding site on mammalian GABAA receptors identified by photolabeling","volume":"9","author":"Yip","year":"2013","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0350","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1476-5381.2011.01318.x","article-title":"Predictive animal models of mania: hits, misses and future directions","volume":"164","author":"Young","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0355","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/7854_2015_5015","article-title":"Locomotor profiling from rodents to the clinic and back again","volume":"28","author":"Young","year":"2016","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.ebiom.2018.07.031_bb0360","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0285-16.2017","article-title":"A negative allosteric modulator for alpha5 subunit-containing GABA receptors exerts a rapid and persistent antidepressant-like action without the side effects of the NMDA receptor antagonist ketamine in mice","volume":"4","author":"Zanos","year":"2017","journal-title":"eNeuro"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418302743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418302743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:48:56Z","timestamp":1762454936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396418302743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":72,"alternative-id":["S2352396418302743"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.07.031","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quercetin Reduces Cortical GABAergic Transmission and Alleviates MK-801-Induced Hyperactivity","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}